Schizophrenia

...ba href=/schizophrenia/a/b, and is marketed worldwide by Janssen-Cilag (Janssen), a wholly owned division of Johnson & Johnson.

Alkermes' lead proprietary product candidate, VIVITROL™ (naltrexone for extended-release injectable suspension), is being developed as a once-monthly injection for the treatment of alcohol dependence.

Alkermes has a pipeline of extended-release injectable products and pulmonary drug products based on its proprietary technology and expertise.

Alkermes' product development strategy is twofold: Alkermes partners its proprietary technology systems and drug delivery expertise with several of the world's finest pharmaceutical companies and it also develops novel, proprietary drug candidates for its own account.

Alkermes' headquarters are in Cambridge, Massachusetts, and it operates research and manufacturing facilities in Massachusetts and Ohio.

Source: Eli Lilly and Co.

The Show Privacy Statement ...

...ba href=/schizophrenia/a/b.

Full-text articles are available, free, online at www.rehab.research.va.gov.

Majority of veterans with spinal cord injury report chronic pain, pg.

573 In a telephone survey of veterans with spinal cord injury (SCI), 76 percent of participants reported chronic pain.

A group of veterans with SCI who received care from one regional Department of Veterans Affairs SCI Center during a 3-year period completed a telephone survey about pain frequency, duration, intensity, exacerbating factors, and effects on daily activities.

The majority of the chronic pain components occurred daily and lasted most of the day.

Average pain intensity in the week before the interview was high-moderate to severe, while worst pain intensity was severe.

Two-thirds of the chronic pain components interfered with daily activities.

Chronic pain patterns stable in patients with spinal cord injury, pg.

585 In a recent study of pain and spinal cord injury (SCI), investigators found that specific pain patterns (e.g., pain below the level of injury, upper-limb pain in tetraplegia, and severe, persistent pain) were stable in chronic SCI.

They conducted two surveys 18 months apart to examine the stability of pain characteristics and pain-induced interference with sleep and daily activities.

While pain locations, pain descriptors, pain intensities, and temporal aspects were similar between surveys, aching pain and sleep interference significantly increased.

Information about the long-term course of pa...

...ba href=/schizophrenia/a/b, panic disorder and mood disorders.

"For most of us, the worry of 'losing your mind' is the most disabling thing that can happen to us," the paper states.

It establishes maximum wait times for five "sentinel" mental illnesses: psychosis, mania, hypomania, postpartum mood disorder, major depression.

According to Health Canada, more than four million Canadians are suffering from an identifiable mental illness at any given time.

Only one-third of them are getting treatment.

While there are no good data on the number of patients actually waiting for psychiatric care, anecdotally, the situation appears grim.

"Most psychiatrists don't even keep wait lists because they would be too long," said Dr.

Blake Woodside, chairman of the Canadian Psychiatric Association and director of the eating-disorders program at Toronto General Hospital.

Waits are longest for children, and in rural communities, particularly remote aboriginal communities.

Dr.

Woodside said what is truly tragic is that delays in treatment routinely result in a worsening of a person's condition and worse outcomes - at great cost to individuals and the health system.

"Right now, if you show up in ER suicidal, you will get care, but if you want a consultation for a serious mental-health problem, it will take many months to be seen," Dr.

Woodside said.

He said it is important to bear in mind that, while people are waiting for care, patients "are often not leading productive lives - they can't work, they can't...